Delivery Order SPE2DB20D2104-SPE2DB24FR21N

Award Date 11/16/23
Potential Completion Date 11/17/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Januvia 50 mg tablets. The $2,316.12 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 22, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Januvia 100mg tablets to support the medical needs of the U.S. Department of Defense. The $37,745.06 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer for AmerisourceBergen's federal contracting activities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Januvia 100 mg tablets. The contract, valued at $2,197.26, is a delivery order with a firm fixed price. The ultimate completion date is December 23, 2024, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Januvia 50 mg tablets to the Medical Supply Chain of the Defense Logistics Agency (DLA). The $1,900.24 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,819.10, is for the delivery of Januvia 100 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Januvia 50 mg tablets. The contract, valued at $1,087.41, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Januvia 50 mg tablets. The $6,181.67 Firm Fixed Price Delivery Order has a completion date of July 3, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Januvia 100 mg tablets. The $18,923.61 firm-fixed-price delivery order contract has a completion date of May 28, 2024 and does not include a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Januvia 50 mg tablets. The contract, valued at $2,316.00, has a firm fixed price and an ultimate completion date of February 26, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,329.20 firm-fixed-price delivery order is for the supply of Januvia 50 mg tablets and has an ultimate completion date of August 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR21N
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Januvia 50 mg tablets. The $1,129.90 firm-fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 17, 2023.

The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:14 PM